These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10325933)

  • 21. Calcium oxalate crystallization in undiluted postprandial urine of healthy male volunteers as influenced by citrate.
    Fan J; Schwille PO; Schmiedl A; Fink E; Manoharan M
    Arzneimittelforschung; 2001 Oct; 51(10):848-57. PubMed ID: 11715639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A
    Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone].
    Parent X; Boess G; Brignon P
    Prog Urol; 1999 Dec; 9(6):1051-6. PubMed ID: 10658250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium oxalate stone formation risk - a case of disturbed relative concentrations of urinary components.
    Laube N; Rodgers A; Allie-Hamdulay S; Straub M
    Clin Chem Lab Med; 2008; 46(8):1134-9. PubMed ID: 18578688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pH on the urinary inhibition of calcium oxalate crystal growth.
    Tiselius HG
    Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Computer calculations on the effect of urine components on saturation relations of calcium oxalate in the urine].
    Matouschek E; Huber RD
    Urologe A; 1984 Mar; 23(2):70-6. PubMed ID: 6547011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High urinary excretion level of citrate and magnesium in children: potential etiology for the reduced incidence of pediatric urolithiasis.
    Miyake O; Yoshimura K; Yoshioka T; Koide T; Okuyama A
    Urol Res; 1998; 26(3):209-13. PubMed ID: 9694604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
    Hannak D; Burczyk U; Bartelt U; Kattermann R
    Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Granulated potassium citrate in the prevention of calcium oxalate lithiasis].
    Campoy Martínez P; Arrabal Martín M; Quintero Rodríguez R; Espinosa Olmedo FJ; Castillo Gómez J; García Pérez M
    Actas Urol Esp; 1994 Feb; 18(2):101-5. PubMed ID: 7976691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical value of crystalluria study].
    Daudon M; Jungers P; Lacour B
    Ann Biol Clin (Paris); 2004; 62(4):379-93. PubMed ID: 15297232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium oxalate dihydrate formation in urine.
    Martin X; Smith LH; Werness PG
    Kidney Int; 1984 Jun; 25(6):948-52. PubMed ID: 6471675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute oral calcium-sodium citrate load in healthy males. Effects on acid-base and mineral metabolism, oxalate and other risk factors of stone formation in urine.
    Schwille PO; Schmiedl A; Herrmann U; Schwille R; Fink E; Manoharan M
    Methods Find Exp Clin Pharmacol; 1997; 19(6):417-27. PubMed ID: 9385591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronopharmacological studies on potassium citrate treatment of oxalocalcic urolithiasis.
    Grases F; Conte A; March JG; García-Ferragut L; Villalonga N
    Int Urol Nephrol; 1997; 29(3):263-73. PubMed ID: 9285296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical effects of potassium citrate in the treatment of calcium oxalate lithiasis].
    Conte Visús A; Ibarz Servio L; Arrabal Martín M; Ibarz Navarro JM; Ruiz Marcellán FJ
    Arch Esp Urol; 1994 Mar; 47(2):141-50. PubMed ID: 8002670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.
    Rodgers A; Allie-Hamdulay S; Jackson G
    Nephrol Dial Transplant; 2006 Feb; 21(2):361-9. PubMed ID: 16249202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.